// App-Quantinova.ai

P1.099 : Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer’s disease (P1.099)

Researchers

Presenter

  • Kok Pin Ng

Principal Investigators

  • Tharick A. Pascoal

  • Sulantha Mathotaarachchi

  • Chang-Oh Chung

  • Andrea L. Benedet

  • Monica Shin

  • Min Su Kang

  • Xiaofeng Li

  • Maowen Ba

  • Nagaendran Kandiah

  • Pedro Rosa-Neto

  • Serge Gauthier

Medical Centers

  • The McGill University Research Centre for Studies in Aging Montreal QC Canada

  • National Neuroscience Institute Montreal QC Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • 18F-fluorodeoxyglucose

  • Cerebrospinal fluid

Drug/Treatment

  • Florbetapir

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • The Alzheimer’s Disease Neuroimaging Initiative (ADNI) And dod ADNI (Department of Defense)

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved